(Q36989557)

English

A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers

scientific article published on 21 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

John H Stewart

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Perry Shen

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Greg Russell

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Joyce Fenstermaker

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Libby McWilliams

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Faith M Coldrun

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Keith E Levine

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Bradley T Jones

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Edward A Levine

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

21 May 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

2137-2145

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Oxaliplatin: pharmacokinetics and chronopharmacological aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

29 September 2017

Prophylactic and therapeutic continuous hyperthermic peritoneal perfusion for peritoneal metastases of gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

27 June 2018

Immune dysfunction in children after corrective surgery for congenital heart disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

27 June 2018

HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

Off-pump coronary artery bypass grafting does not reduce lymphocyte activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

Immunologic postoperative competence after laparoscopy versus laparotomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

A distributed model of peritoneal-plasma transport: theoretical considerations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703640

4 September 2018

Peritoneal carcinomatosis from colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18493824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18493824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between clinical parameters and pharmacokinetics of mitomycin C

1 reference

https://pubmed.ncbi.nlm.nih.gov/18493824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic characteristics of 5-fluorouracil and mitomycin C in intraperitoneal chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18493824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1245/S10434-008-9967-1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36989557&oldid=2199697828"